Literature DB >> 16246290

Synthesis and study of the electrophoretic behavior of mannan conjugates with cyclic peptide analogue of myelin basic protein using lysine-glycine linker.

Theodore V Tselios1, Fotini N Lamari, Ioanna Karathanasopoulou, Maria Katsara, Vasso Apostolopoulos, Geoffrey A Pietersz, John M Matsoukas, Nikos K Karamanos.   

Abstract

New approaches for the treatment of multiple sclerosis involve the design and synthesis of peptide or nonpeptide analogues of myelin sheath, which could alter the immune response of patients. For this purpose, the cyclo(75-82) myelin basic protein (MBP)(74-85) analogue was conjugated to mannan (a polymannose) via (Lys-Gly)(5) linker. Monitoring of synthesis of the (Lys-Gly)(5)-containing cyclic analogue of MBP, mannan oxidation, and the conjugation reaction of this analogue to oxidized mannan was performed with capillary electrophoresis (CE) in operating buffers of different pH values. The (Lys-Gly)(5)cyclo(75-82)MBP(74-85) was efficiently synthesized by solid-phase synthesis and purified to a high degree, as confirmed by CE analysis in a low-pH (3.0) phosphate buffer and normal polarity. Oxidation of mannan was monitored using a high-pH (9.3) borate buffer, and the generation of heterogeneous products and even UV-absorbing peaks was shown by CE. CE analysis in a pH 5.1 phosphate buffer offers high resolution of oxidized mannan and the conjugation product and can be used for screening of the reaction products. Mannan-peptide conjugates of varying degrees of substitution and unreacted mannan were observed. The developed CE analysis presents distinct advantages over sodium dodecyl sulfate-polyacrylamide gel electrophoresis such as high versatility, high separation efficiency, short analysis time, low cost, and low solvent consumption.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246290     DOI: 10.1016/j.ab.2005.09.014

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  7 in total

1.  Perfluoro-tert-butanol for selective on-resin detritylation: a mild alternative to traditionally used methods.

Authors:  Anita Wester; Anna Mette Hansen; Paul R Hansen; Henrik Franzyk
Journal:  Amino Acids       Date:  2021-08-19       Impact factor: 3.520

2.  Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in mice.

Authors:  Maria Katsara; Elizabeth Yuriev; Paul A Ramsland; Theodore Tselios; George Deraos; Athanasios Lourbopoulos; Nikolaos Grigoriadis; John Matsoukas; Vasso Apostolopoulos
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

3.  Mannosylated Linear and Cyclic Single Amino Acid Mutant Peptides Using a Small 10 Amino Acid Linker Constitute Promising Candidates Against Multiple Sclerosis.

Authors:  Stephanie Day; Theodore Tselios; Maria-Eleni Androutsou; Anthi Tapeinou; Irene Frilligou; Lily Stojanovska; John Matsoukas; Vasso Apostolopoulos
Journal:  Front Immunol       Date:  2015-04-07       Impact factor: 7.561

Review 4.  Targeting antigens to dendritic cell receptors for vaccine development.

Authors:  Vasso Apostolopoulos; Theresia Thalhammer; Andreas G Tzakos; Lily Stojanovska
Journal:  J Drug Deliv       Date:  2013-10-08

Review 5.  Multiple Sclerosis: Immunopathology and Treatment Update.

Authors:  Narges Dargahi; Maria Katsara; Theodore Tselios; Maria-Eleni Androutsou; Maximilian de Courten; John Matsoukas; Vasso Apostolopoulos
Journal:  Brain Sci       Date:  2017-07-07

6.  The Long Road of Immunotherapeutics against Multiple Sclerosis.

Authors:  Vasso Apostolopoulos; Abdolmohamad Rostami; John Matsoukas
Journal:  Brain Sci       Date:  2020-05-11

7.  Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.

Authors:  Anastasia Dagkonaki; Maria Avloniti; Maria Evangelidou; Irini Papazian; Ioannis Kanistras; Vivian Tseveleki; Fotis Lampros; Theodore Tselios; Lise Torp Jensen; Wiebke Möbius; Torben Ruhwedel; Maria-Eleni Androutsou; John Matsoukas; Maria Anagnostouli; Hans Lassmann; Lesley Probert
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.